Cetuximab: all 645 studies that test it

Page 3 of 7. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
• Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerCompletedNCT00551421Phase 1/2Results posted
• Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan TreatmentTerminatedNCT00538291Phase 2Results posted
• Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementTerminatedNCT00537823Phase 2Results posted
• High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00533949Phase 3Results posted
• Pre-op Rectal ChemoRad +/- CetuximabCompletedNCT00527111Phase 2Results posted
• Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractCompletedNCT00524017Phase 2Results posted
• Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCTerminatedNCT00519831Phase 2Results posted
• Docetaxel+Oxali+/-Cetux Met Gastric/GEJCompletedNCT00517829Phase 2Results posted
• Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR TherapyCompletedNCT00503685Phase 2Results posted
• Cetuximab in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00499031Phase 2Results posted
• Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLCCompletedNCT00492206Phase 2Results posted
• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver CancerCompletedNCT00483405Phase 2Results posted
• Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT00466505Phase 2Results posted
• Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast CancerCompletedNCT00463788Phase 2Results posted
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerCompletedNCT00462735Phase 2Results posted
• Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal CancerCompletedNCT00444678Phase 2Results posted
• Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric CancerCompletedNCT00439608Phase 2Results posted
• Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal AdenocarcinomaTerminatedNCT00430027Not applicableResults posted
• A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00409565Phase 2Results posted
• Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00408564Phase 2Results posted
• Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung CancerCompletedNCT00408499Phase 1/2Results posted
• Study of XELOX With Cetuximab in Advanced Gastric CancerCompletedNCT00398398Phase 2Results posted
• Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinCompletedNCT00397904Phase 2Results posted
• Cetuximab in Patients With Progressive or Recurrent Endometrial CancerCompletedNCT00392769Phase 2Results posted
• A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic CancerCompletedNCT00383149Phase 2Results posted
• S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00368992Phase 2Results posted
• A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLCCompletedNCT00343291Phase 2Results posted
• Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)CompletedNCT00343083Phase 2Results posted
• Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer PatientsCompletedNCT00338039Phase 2Results posted
• Irinotecan and Cetuximab for Colorectal Cancer as Second Line TherapyCompletedNCT00336856Phase 2Results posted
• BAY 43-9006 Plus Cetuximab to Treat Colorectal CancerCompletedNCT00326495Phase 2Results posted
• Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerCompletedNCT00324415Phase 2Results posted
• Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With CetuximabTerminatedNCT00319839Phase 2Results posted
• Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerCompletedNCT00316888Phase 2Results posted
• Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryCompletedNCT00305877Phase 2Results posted
• Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00305760Phase 2Results posted
• Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck CancerCompletedNCT00301028Phase 2Results posted
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00290615Phase 2Results posted
• Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
• A Study of Mitomycin C, Irinotecan, and CetuximabTerminatedNCT00271011Phase 2Results posted
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00265941Phase 3Results posted
• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00265850Phase 3Results posted
• Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerCompletedNCT00252564Phase 3Results posted
• PhII ICb With/Without Erbitux in MBC PtsActive, not recruitingNCT00248287Phase 2Results posted
• Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerCompletedNCT00226239Phase 2Results posted
• Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic CancerCompletedNCT00225784Phase 2Results posted
• Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung CancerCompletedNCT00216203Phase 1/2Results posted
• Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung CancerCompletedNCT00193453Phase 2Results posted
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal CancerCompletedNCT00193219Phase 2Results posted
• Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)CompletedNCT00154102Phase 3Results posted
• Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)CompletedNCT00148798Phase 3Results posted
• Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony SarcomasCompletedNCT00148109Phase 2Results posted
• Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric CancerCompletedNCT00130689Phase 2Results posted
• Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)CompletedNCT00125034Phase 2Results posted
• Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00124618Phase 2Results posted
• Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00117962Phase 2Results posted
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00112294Phase 3Results posted
• Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid TumorsCompletedNCT00110357Phase 1Results posted
• S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal CancerTerminatedNCT00109850Phase 2Results posted
• Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung CancerCompletedNCT00103207Phase 2Results posted
• Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00101192Phase 2Results posted
• Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerCompletedNCT00100841Phase 2Results posted
• Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00096174Phase 2Results posted
• S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00096031Phase 2Results posted
• Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung CancerCompletedNCT00095199Phase 3Results posted
• Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00091026Phase 2Results posted
• Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck CancerCompletedNCT00089297Phase 2Results posted
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to ChemotherapyCompletedNCT00083720Phase 2Results posted
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon CancerCompletedNCT00079274Phase 3Results posted
• Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00042939Phase 2Results posted
• A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell CarcinomaCompletedNCT07435324Phase 3
• A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell CarcinomaCompletedNCT07435311Phase 1
• SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal CancerCompletedNCT06908031Phase 2
• Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCCActive, not recruitingNCT06855212Phase 2
• A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab AloneActive, not recruitingNCT06806852Phase 1
• Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRCActive, not recruitingNCT06578559Phase 2
• The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal CancerActive, not recruitingNCT06540261Phase 1
• AK117 (Anti-CD47 mAb) Plus Cetuximab as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT06508606Phase 2
• Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic LeukemiaSuspendedNCT06447987Phase 1
• Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)Active, not recruitingNCT06358430Phase 1
• Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer PatientsTerminatedNCT06332079Phase 2
• A Study of BND-35 in Participants With Advanced Solid TumorsTerminatedNCT06274437Phase 1
• Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal CancerCompletedNCT05954871Phase 1
• Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis PatientStatus unknownNCT05873972Not applicable
• Pilot Study of Imatinib Cetuximab Combo for H & N CancerCompletedNCT05816785Early Phase 1
• Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal CancerStatus unknownNCT05799443Phase 2
• Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal CancerCompletedNCT05775900Phase 1/2
• Quintuple Method for Treatment of Multiple Refractory Colorectal Liver MetastasesStatus unknownNCT05774964Phase 2
• A Study of GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C MutationCompletedNCT05756153Phase 1/2
• ZN-c3 in Adult Participants With Metastatic Colorectal CancerTerminatedNCT05743036Phase 1
• Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal CancerActive, not recruitingNCT05722327Phase 1
• Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCCCompletedNCT05721443Phase 2
• Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon CancerActive, not recruitingNCT05710406Phase 2/3
• A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal CancerStatus unknownNCT05684211Phase 2
• Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC PatientsCompletedNCT05673577Phase 2
• Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II StudyActive, not recruitingNCT05586100Phase 2
• A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal CancerTerminatedNCT05497336Phase 1
• CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment RegimenActive, not recruitingNCT05312398Phase 2
• A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver CancerCompletedNCT05249426Phase 1

← Cetuximab overview